SCHEMBL1552501

SCHEMBL1552501

O=C(Nc1ccc(Br)cc1)OCC1CCSc2ccccc2C1=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
PTGIR P43119 1/20 0.38
BCHE P06276 3/20 0.36
TSHR P16473 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MAOB P27338 2/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ACHE P22303 1/20 0.36
CHRNA7 P36544 3/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
HTT P42858 1/20 0.36
EPHX2 P34913 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1551475 0.91 PTGIR (0.46) KMT2AMEN1PTGIRBCHETSHR
SCHEMBL1552094 0.80 MGLL (0.46) KMT2AMEN1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4950715 0.80 PTGIR (0.45) KMT2AMEN1PTGIRBCHETSHR
SCHEMBL1552072 0.78 EPHX1 (0.45) KMT2ABCHERAB9AALDH1A1
SCHEMBL1551495 0.76 KMT2A (0.40) KMT2A
SCHEMBL1552089 0.73 NFKB1 (0.41) ALDH1A1
SCHEMBL1552752 0.71 HPGD (0.39) NPC1ALDH1A1
SCHEMBL14913645 0.70 EPHX2 (0.64) KMT2AMEN1NPC1RAB9AMAOB
SCHEMBL7288534 0.70 TP53 (0.41) NPC1ALDH1A1ITGB3ITGA2B
SCHEMBL1552074 0.67 SMN1; SMN2 (0.39) KMT2AMEN1PTGIRBCHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891035-B1 SUBSTITUTED BENZO-CONDENSED CYCLOHEPTANONE DERIVATIVES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2011-04-27 EP claimed
US-7858613-B2 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs GRUENENTHAL GMBH (DE) 2010-12-28 US claimed
US-20090215858-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives And Their Use For Producing Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-7858613-B2 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs GRUENENTHAL GMBH (DE) 2010-12-28 US disclosed
US-20090215858-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives And Their Use For Producing Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215858-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives And Their Use For Producing Drugs ABCB1, DHFR, DHPS KMT2A 3228/4885MEN1 3574/4885PTGIR 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.